Vaccine partner site

Remington-Davis’ extensive experience allows us to consistently surpass study start up timelines and vaccine study enrollment goals. We ensure high quality data and deliver engaged patients in both government and industry sponsored clinical trials. We have completed over 575 clinical trials since 1992. A few examples of our experience include:

  • Three separate C. difficile vaccine studies wherein an average of 50 subjects were randomized per study
  • Seasonal Influenza Vaccine study; rapid study start up and enrollment mattered
  • Two government anti-botulism vaccine studies with an average of 21 enrolled healthy adult volunteers per study
  • Staph Aureus Vaccine study with 52 randomized subjects

Phase I-IV trial experience

Recently remodeled, the facility has added the capability to sleep up to four patients per night. Each private room is equipped with a desk, bed, recliner, end table, and television. An on-site kitchen where meals are prepared, or brought in, and a full bathroom with handicapped accessible shower are steps away from each patient room.

Staff is a combination of licensed and certified full-time study coordinators and nurses, supported by a dedicated regulatory department, quality assurance department, and patient recruiter. The management team has over 100 years of combined research experience.

Our team has experience in over 20 therapeutic indications:
  • Critical Care
  • Infectious Disease
  • Gastroenterology
  • Orthopedics
  • Pulmonology
  • Nephrology
  • Internal Medicine
  • Family Practice
  • Urology
  • Vascular Medicine
  • Dermatology
  • Device Feasibility
  • Endocrinology
  • Laboratory Validation
  • Vaccines
  • Human Factors

Choose results. Choose Remington-Davis.